SCHEMBL8779128

SCHEMBL8779128

O=C1c2cc(Cl)ccc2CCC12CCCC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 1/20 0.46
PARP1 P09874 1/20 0.46
F3 P13726 1/20 0.46
PARP10 Q53GL7 1/20 0.46
SIGMAR1 Q99720 7/20 0.45
HTR2A P28223 5/20 0.45
HTR2C P28335 5/20 0.45
HTR2B P41595 5/20 0.45
DRD2 P14416 5/20 0.45
KDM1A O60341 1/20 0.38
PDE7A Q13946 2/20 0.38
PPOX P50336 1/20 0.38
CMA1 P23946 1/20 0.38
AHR P35869 1/20 0.38
SRD5A1 P18405 1/20 0.38
S100A4 P26447 1/20 0.37
TYMS P04818 2/20 0.37
METAP1 P53582 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8779094 0.87 SIGMAR1 (0.57) F7PARP1F3PARP10SIGMAR1
SCHEMBL8779154 0.80 PARP1 (0.46) PARP1PARP10SIGMAR1HTR2AHTR2C
SCHEMBL8779101 0.80 TDP1 (0.50) PARP1PARP10SIGMAR1HTR2AHTR2C
SCHEMBL22892512 0.80 SIGMAR1 (0.46) PARP1PARP10SIGMAR1HTR2AHTR2C
SCHEMBL8779056 0.80 F7 (0.39) F7PARP1F3PARP10SIGMAR1
SCHEMBL8778995 0.80 SIGMAR1 (0.43) PARP1SIGMAR1HTR2AHTR2CHTR2B
SCHEMBL8779110 0.80 SIGMAR1 (0.43) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL7887821 0.80 HTR2A (0.45) F7PARP1F3PARP10SIGMAR1
SCHEMBL8779030 0.79 SIGMAR1 (0.39) SIGMAR1HTR2AHTR2CHTR2BDRD2
SCHEMBL6836353 0.77 SIGMAR1 (0.62) SIGMAR1HTR2AHTR2CHTR2BDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606661-B1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists HOFFMANN LA ROCHE (CH) 1997-03-12 EP disclosed
US-5385947-A For prevention of nerve damage due to reduction of blood or oxygen supplies HOFFMANN-LA ROCHE INC. (US) 1995-01-31 US disclosed
EP-0606661-A1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists F. HOFFMANN-LA ROCHE AG (CH) 1994-07-20 EP disclosed